• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DNA 依赖性蛋白激酶催化亚基(DNA-PKcs):超越 DNA 双链断裂修复。

DNA-Dependent Protein Kinase Catalytic Subunit (DNA-PKcs): Beyond the DNA Double-Strand Break Repair.

机构信息

College of Veterinary Medicine, Seoul National University, Seoul 08826, Korea.

出版信息

Mol Cells. 2023 Apr 30;46(4):200-205. doi: 10.14348/molcells.2023.2164. Epub 2023 Feb 9.

DOI:10.14348/molcells.2023.2164
PMID:36756777
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10086554/
Abstract

DNA-dependent protein kinase catalytic subunit (DNA-PKcs), a member of the phosphatidylinositol 3-kinase related kinase family is a well-known player in repairing DNA double strand break through non-homologous end joining pathway. This mechanism has allowed us to understand its critical role in T and B cell development through V(D)J recombination and class switch recombination, respectively. We have also learned that the defects in these mechanisms lead to severely combined immunodeficiency (SCID). Here we highlight some of the latest evidence where DNA-PKcs has been shown to localize not only in the nucleus but also in the cytoplasm, phosphorylating various proteins involved in cellular metabolism and cytokine production. While it is an exciting time to unveil novel functions of DNA-PKcs, one should carefully choose experimental models to study DNA-PKcs as the experimental evidence has been shown to differ between cells of defective DNA-PKcs and those of knockout. Moreover, while there are several DNA-PK inhibitors currently being evaluated in the clinical trials in attempt to increase the efficacy of radiotherapy or chemotherapy, multiple functions and subcellular localization of DNA-PKcs in various types of cells may further complicate the effects at the cellular and organismal level.

摘要

DNA 依赖性蛋白激酶催化亚基(DNA-PKcs)是磷脂酰肌醇 3-激酶相关激酶家族的成员,是通过非同源末端连接途径修复 DNA 双链断裂的知名参与者。这一机制使我们能够分别通过 V(D)J 重组和类别转换重组来理解其在 T 和 B 细胞发育中的关键作用。我们还了解到,这些机制的缺陷会导致严重联合免疫缺陷(SCID)。在这里,我们重点介绍了一些最新的证据,表明 DNA-PKcs 不仅定位于细胞核,还定位于细胞质,磷酸化参与细胞代谢和细胞因子产生的各种蛋白质。虽然揭示 DNA-PKcs 的新功能是令人兴奋的,但应该仔细选择实验模型来研究 DNA-PKcs,因为已经证明有缺陷的 DNA-PKcs 细胞和敲除细胞之间的实验证据存在差异。此外,虽然目前有几种 DNA-PK 抑制剂正在临床试验中评估,以试图提高放疗或化疗的疗效,但 DNA-PKcs 在各种类型细胞中的多种功能和亚细胞定位可能会进一步使细胞和机体水平的影响复杂化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96e6/10086554/d734c3f02d94/molce-46-4-200-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96e6/10086554/7925afeba14b/molce-46-4-200-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96e6/10086554/d734c3f02d94/molce-46-4-200-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96e6/10086554/7925afeba14b/molce-46-4-200-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96e6/10086554/d734c3f02d94/molce-46-4-200-f2.jpg

相似文献

1
DNA-Dependent Protein Kinase Catalytic Subunit (DNA-PKcs): Beyond the DNA Double-Strand Break Repair.DNA 依赖性蛋白激酶催化亚基(DNA-PKcs):超越 DNA 双链断裂修复。
Mol Cells. 2023 Apr 30;46(4):200-205. doi: 10.14348/molcells.2023.2164. Epub 2023 Feb 9.
2
Functional redundancy between the XLF and DNA-PKcs DNA repair factors in V(D)J recombination and nonhomologous DNA end joining.XLF 和 DNA-PKcs 在 V(D)J 重组和非同源 DNA 末端连接中的 DNA 修复因子功能冗余。
Proc Natl Acad Sci U S A. 2013 Feb 5;110(6):2234-9. doi: 10.1073/pnas.1222573110. Epub 2013 Jan 23.
3
Functional intersection of ATM and DNA-dependent protein kinase catalytic subunit in coding end joining during V(D)J recombination.ATM 和 DNA 依赖性蛋白激酶催化亚基在 V(D)J 重组编码末端连接中的功能交集。
Mol Cell Biol. 2013 Sep;33(18):3568-79. doi: 10.1128/MCB.00308-13. Epub 2013 Jul 8.
4
DNA-PKcs Is Involved in Ig Class Switch Recombination in Human B Cells.DNA依赖蛋白激酶催化亚基参与人类B细胞中的免疫球蛋白类别转换重组。
J Immunol. 2015 Dec 15;195(12):5608-15. doi: 10.4049/jimmunol.1501633. Epub 2015 Nov 6.
5
Phosphorylation at S2053 in Murine (S2056 in Human) DNA-PKcs Is Dispensable for Lymphocyte Development and Class Switch Recombination.在鼠类(人类为 S2056)DNA-PKcs 的 S2053 位点磷酸化对于淋巴细胞发育和类别转换重组是可有可无的。
J Immunol. 2019 Jul 1;203(1):178-187. doi: 10.4049/jimmunol.1801657. Epub 2019 May 17.
6
DNA-PKcs phosphorylation at the T2609 cluster alters the repair pathway choice during immunoglobulin class switch recombination.DNA-PKcs 在 T2609 簇的磷酸化改变了免疫球蛋白类别转换重组过程中的修复途径选择。
Proc Natl Acad Sci U S A. 2020 Sep 15;117(37):22953-22961. doi: 10.1073/pnas.2007455117. Epub 2020 Aug 31.
7
DNA-Dependent Protein Kinase Catalytic Subunit: The Sensor for DNA Double-Strand Breaks Structurally and Functionally Related to Ataxia Telangiectasia Mutated.DNA 依赖性蛋白激酶催化亚单位:与共济失调毛细血管扩张突变蛋白在结构和功能上相关的 DNA 双链断裂感受器。
Genes (Basel). 2021 Jul 27;12(8):1143. doi: 10.3390/genes12081143.
8
Barrier-to-autointegration-factor (Banf1) modulates DNA double-strand break repair pathway choice via regulation of DNA-dependent kinase (DNA-PK) activity.屏障整合因子 1(Banf1)通过调节 DNA 依赖性激酶(DNA-PK)活性来调节 DNA 双链断裂修复途径的选择。
Nucleic Acids Res. 2021 Apr 6;49(6):3294-3307. doi: 10.1093/nar/gkab110.
9
Autophosphorylation and Self-Activation of DNA-Dependent Protein Kinase.DNA 依赖性蛋白激酶的自动磷酸化和自我激活。
Genes (Basel). 2021 Jul 19;12(7):1091. doi: 10.3390/genes12071091.
10
Structural analysis of the basal state of the Artemis:DNA-PKcs complex.Artemis:DNA-PKcs 复合物的基础状态的结构分析。
Nucleic Acids Res. 2022 Jul 22;50(13):7697-7720. doi: 10.1093/nar/gkac564.

引用本文的文献

1
Generation of NOD SCID mice with near-complete deletions of Il2rg and Prkdc for human cancer and HSC engraftment.用于人类癌症和造血干细胞植入的Il2rg和Prkdc近乎完全缺失的NOD SCID小鼠的生成。
Transgenic Res. 2025 Jul 11;34(1):35. doi: 10.1007/s11248-025-00454-9.
2
Exploring intracellular anti-mycobacterium activity of lactoferricin-loaded niosomes: proteomics insights into Immunomodulation.探索载乳铁蛋白的非离子型表面活性剂囊泡的细胞内抗分枝杆菌活性:蛋白质组学对免疫调节的见解
Sci Rep. 2025 May 30;15(1):19029. doi: 10.1038/s41598-025-04673-2.
3
The DNA-PK inhibitor AZD7648 alone or combined with pegylated liposomal doxorubicin in patients with advanced cancer: results of a first-in-human Phase I/IIa study.

本文引用的文献

1
A Novel Role for DNA-PK in Metabolism by Regulating Glycolysis in Castration-Resistant Prostate Cancer.DNA-PK 在代谢中的新作用:通过调节去势抵抗性前列腺癌中的糖酵解。
Clin Cancer Res. 2022 Apr 1;28(7):1446-1459. doi: 10.1158/1078-0432.CCR-21-1846.
2
HIF-1 Interacts with TRIM28 and DNA-PK to release paused RNA polymerase II and activate target gene transcription in response to hypoxia.缺氧条件下,HIF-1 与 TRIM28 和 DNA-PK 相互作用,释放暂停的 RNA 聚合酶 II,并激活靶基因转录。
Nat Commun. 2022 Jan 14;13(1):316. doi: 10.1038/s41467-021-27944-8.
3
DNA-PKcs kinase activity stabilizes the transcription factor Egr1 in activated immune cells.
DNA依赖蛋白激酶抑制剂AZD7648单药或联合聚乙二醇化脂质体阿霉素治疗晚期癌症患者:一项I/IIa期人体首次研究的结果
Br J Cancer. 2025 May 17. doi: 10.1038/s41416-025-03053-x.
4
Controversy and multiple roles of the solitary nucleus receptor Nur77 in disease and physiology.孤核受体Nur77在疾病与生理学中的争议及多重作用
FASEB J. 2025 Mar 31;39(6):e70468. doi: 10.1096/fj.202402775RR.
5
Altered KEGG pathways are associated with different immunologic responses to antiretroviral therapy in HIV-infected men who have sex with men.KEGG通路的改变与男男性行为HIV感染者对抗逆转录病毒治疗的不同免疫反应相关。
BMC Infect Dis. 2025 Mar 11;25(1):343. doi: 10.1186/s12879-025-10756-2.
6
HDGF Knockout Suppresses Colorectal Cancer Progression and Drug Resistance by Modulating the DNA Damage Response.HDGF基因敲除通过调节DNA损伤反应抑制结直肠癌进展和耐药性。
Biomolecules. 2025 Feb 14;15(2):282. doi: 10.3390/biom15020282.
7
N-Methyladenosine modification mediated by METTL3 promotes DNA-PKcs expression to induce anlotinib resistance in osteosarcoma.由METTL3介导的N-甲基腺苷修饰促进DNA-PKcs表达,从而诱导骨肉瘤对安罗替尼产生耐药性。
Clin Transl Med. 2025 Feb;15(2):e70228. doi: 10.1002/ctm2.70228.
8
USP14 inhibition promotes DNA damage repair and represses ovarian granulosa cell senescence in premature ovarian insufficiency.USP14 抑制促进 DNA 损伤修复并抑制早发性卵巢功能不全中的卵巢颗粒细胞衰老。
J Transl Med. 2024 Sep 11;22(1):834. doi: 10.1186/s12967-024-05636-3.
9
Recent advances in serum response factor posttranslational modifications and their therapeutic potential in cardiovascular and neurological diseases.血清反应因子翻译后修饰的最新进展及其在心血管和神经疾病中的治疗潜力。
Vascul Pharmacol. 2024 Sep;156:107421. doi: 10.1016/j.vph.2024.107421. Epub 2024 Aug 30.
10
Molecular signaling and clinical implications in the human aging-cancer cycle.人类衰老-癌症循环中的分子信号传导及其临床意义。
Semin Cancer Biol. 2024 Nov;106-107:28-42. doi: 10.1016/j.semcancer.2024.08.003. Epub 2024 Aug 26.
DNA-PKcs 激酶活性可稳定激活免疫细胞中的转录因子 Egr1。
J Biol Chem. 2021 Oct;297(4):101209. doi: 10.1016/j.jbc.2021.101209. Epub 2021 Sep 23.
4
Inhibition of DNA-PK with AZD7648 Sensitizes Tumor Cells to Radiotherapy and Induces Type I IFN-Dependent Durable Tumor Control.使用 AZD7648 抑制 DNA-PK 可增强肿瘤细胞对放疗的敏感性,并诱导 I 型干扰素依赖性的持久肿瘤控制。
Clin Cancer Res. 2021 Aug 1;27(15):4353-4366. doi: 10.1158/1078-0432.CCR-20-3701. Epub 2021 May 19.
5
Clinical Perspectives to Overcome Acquired Resistance to Anti-Programmed Death-1 and Anti-Programmed Death Ligand-1 Therapy in Non-Small Cell Lung Cancer.克服非小细胞肺癌中抗程序性死亡-1和抗程序性死亡配体-1治疗获得性耐药的临床前景
Mol Cells. 2021 May 31;44(5):363-373. doi: 10.14348/molcells.2021.0044.
6
DNA-PKcs: A Multi-Faceted Player in DNA Damage Response.DNA依赖性蛋白激酶催化亚基:DNA损伤反应中的多面角色
Front Genet. 2020 Dec 23;11:607428. doi: 10.3389/fgene.2020.607428. eCollection 2020.
7
DNA-PK deficiency potentiates cGAS-mediated antiviral innate immunity.DNA-PK 缺陷增强 cGAS 介导的抗病毒先天免疫。
Nat Commun. 2020 Dec 3;11(1):6182. doi: 10.1038/s41467-020-19941-0.
8
Beyond DNA Repair: DNA-PKcs in Tumor Metastasis, Metabolism and Immunity.超越DNA修复:DNA依赖蛋白激酶催化亚基在肿瘤转移、代谢及免疫中的作用
Cancers (Basel). 2020 Nov 16;12(11):3389. doi: 10.3390/cancers12113389.
9
Prevalence of PRKDC mutations and association with response to immune checkpoint inhibitors in solid tumors.实体瘤中 PRKDC 突变的流行率及其与免疫检查点抑制剂反应的关系。
Mol Oncol. 2020 Sep;14(9):2096-2110. doi: 10.1002/1878-0261.12739. Epub 2020 Jun 30.
10
Pharmacologic Inhibitor of DNA-PK, M3814, Potentiates Radiotherapy and Regresses Human Tumors in Mouse Models.DNA-PK 药理学抑制剂 M3814 增强放射治疗并在小鼠模型中消退人类肿瘤。
Mol Cancer Ther. 2020 May;19(5):1091-1101. doi: 10.1158/1535-7163.MCT-19-0734. Epub 2020 Mar 27.